The Epivakkorona coronavirus vaccine, developed by the Vector Center for Virology and Biotechnology, is effective against new types of coronavirus, writes TASS with reference to the Rospotrebnadzor press service.
“Mutations characteristic of new strains of coronavirus (British, South African, Brazilian) do not affect the epitopes selected for the Epivaccoron peptide vaccine. The peptides that make up the vaccine are highly conservative, ”the department explained.
Representatives of Rospotrebnadzor noted that the center regularly monitors strains that may affect the effect of the vaccine.
Earlier, Russian President Vladimir Putin instructed the government to analyze the effectiveness of domestic vaccines against new strains of coronavirus.
As a reminder, clinical trials of the drug by the Vector Center ended on September 30. And in mid-October, the vaccine received a registration certificate.